| Product Code: ETC7663581 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel continues to heavily rely on imports of therapeutic vaccines, with top exporting countries in 2024 being Areas, nes, Germany, Spain, USA, and Uruguay. The market shows high concentration, as indicated by the high Herfindahl-Hirschman Index (HHI). Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a significant growth rate of 300.0% from 2023 to 2024, suggesting a potential shift in market dynamics. Israel`s reliance on these imports underscores the importance of international partnerships in ensuring access to critical therapeutic solutions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Therapeutic Vaccines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Israel Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Israel Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Israel Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Therapeutic Vaccines Market Trends |
6 Israel Therapeutic Vaccines Market, By Types |
6.1 Israel Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Israel Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Israel Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Israel Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Israel Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Israel Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Israel Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Israel Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Israel Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Israel Therapeutic Vaccines Market Export to Major Countries |
7.2 Israel Therapeutic Vaccines Market Imports from Major Countries |
8 Israel Therapeutic Vaccines Market Key Performance Indicators |
9 Israel Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Israel Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Israel Therapeutic Vaccines Market - Competitive Landscape |
10.1 Israel Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Israel Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |